Emergence of community-associated methicillin-resistant Staphylococcus aureus strains in the neonatal intensive care unit: an infection prevention and patient safety challenge

Clin Microbiol Infect. 2016 Jul;22(7):645.e1-8. doi: 10.1016/j.cmi.2016.04.013. Epub 2016 Apr 25.

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) infections cause significant morbidity and mortality in neonatal intensive care units (NICUs). We characterized the clinical and molecular epidemiology of MRSA strains colonizing NICU patients. Nasal MRSA isolates (n = 250, from 96 NICU patients) recovered through active surveillance from 2009 to 2014 were characterized with staphylococcal cassette chromosome mec (SCCmec) typing and detection of mupA (marker of high-level mupirocin resistance) and qacA/B (marker associated with chlorhexidine resistance). Factors associated with community-associated (CA-) or healthcare-associated (HA-) MRSA were evaluated. The overall prevalence of MRSA nasal colonization was 3.9%. Of 96 neonates in our retrospective cohort, 60 (63%) were colonized with CA-MRSA strains and 35 (36%) were colonized with HA-MRSA strains. Patients colonized with HA-MRSA were more likely to develop MRSA infections than patients colonized with CA-MRSA (13/35, 37% versus 8/60, 13%; p 0.007), although the interval from colonization to infection was shorter in CA-MRSA-colonized infants (median 0 days, range -1 to 4 versus HA-MRSA-colonized infants, 7 days, -1 to 43; p 0.005). Maternal peripartum antibiotics were associated with CA-MRSA colonization (adjusted odds ratio (aOR) 8.7; 95% CI 1.7-45.0); intubation and surgical procedures were associated with HA-MRSA colonization (aOR 7.8; 95% CI 1.3-47.6 and aOR 6.0; 95% CI 1.4-24.4, respectively). Mupirocin- and chlorhexidine-resistant MRSA was isolated from four and eight patients, respectively; carriage of a mupirocin-resistant strain precluded decolonization. CA-MRSA strains are prominent in the NICU and associated with distinct risk factors. Given community reservoirs for MRSA acquisition and transmission, novel infection prevention strategies are needed.

Keywords: Chlorhexidine; Epidemiology; Infection prevention; Methicillin-resistant Staphylococcus aureus; Mupirocin; Nasal colonization; Neonatal intensive care unit; Staphylococcal cassette chromosome mec.

MeSH terms

  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / pharmacology
  • Carrier State / epidemiology*
  • Carrier State / microbiology
  • Carrier State / prevention & control
  • Chlorhexidine / administration & dosage
  • Chlorhexidine / pharmacology
  • Disease Transmission, Infectious / prevention & control
  • Drug Resistance, Bacterial
  • Female
  • Genotype
  • Humans
  • Infant, Newborn
  • Infection Control / methods*
  • Intensive Care Units, Neonatal*
  • Male
  • Methicillin-Resistant Staphylococcus aureus / classification
  • Methicillin-Resistant Staphylococcus aureus / genetics
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification*
  • Molecular Typing
  • Mupirocin / administration & dosage
  • Mupirocin / pharmacology
  • Nasal Mucosa / microbiology*
  • Patient Safety*
  • Prevalence
  • Retrospective Studies
  • Staphylococcal Infections / epidemiology*
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / prevention & control

Substances

  • Anti-Infective Agents
  • Mupirocin
  • Chlorhexidine